ALLO Return on Tangible Equity | Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. (ALLO) Return on Tangible Equity

2026-06-30: Return Tang Equity -37.94%.
2026-03-31: Return Tang Equity -62.31%.
2025-12-31: Return Tang Equity -65.25%.
2025-09-30: Return Tang Equity -67.24%.

Complete source-backed return tang equity history.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-37.94%
2026-03-31	-62.31%
2025-12-31	-65.25%
2025-09-30	-67.24%
2025-06-30	-68.76%
2025-03-31	-65.47%
2024-12-31	-61.01%
2024-09-30	-61.12%
2024-06-30	-54.25%
2024-03-31	-63.35%
2023-12-31	-63.89%
2023-09-30	-58.34%
2023-06-30	-57.87%
2023-03-31	-60.00%
2022-12-31	-50.24%
2022-09-30	-31.97%
2022-06-30	-28.86%
2022-03-31	-26.45%
2021-12-31	-19.68%
2021-09-30	-25.85%
2021-06-30	-23.32%
2021-03-31	-21.38%
2020-12-31	-24.69%
2020-09-30	-21.69%
2020-06-30	-19.53%
2020-03-31	-34.21%
2019-12-31	-29.35%
2019-09-30	-24.86%
2019-06-30	-22.40%
2019-03-31	-35.30%
2018-12-31	-30.08%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-65.25%
2024-12-31	-61.01%
2023-12-31	-63.89%
2022-12-31	-51.05%
2021-12-31	-19.68%
2020-12-31	-24.69%
2019-12-31	-29.35%
2018-12-31	-30.08%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Prime Medicine, Inc. (PRME)	United States	$0.557B	-3.54
Aura Biosciences, Inc. (AURA)	United States	$0.639B	-5.61
Autolus Therapeutics plc (AUTL)		$0.506B	-1.52
Entera Bio Ltd. (ENTX)		$0.485B
REGENXBIO Inc. (RGNX)	United States	$0.477B	-3.30
Tectonic Therapeutic, Inc. (TECX)	United States	$0.469B	-7.68
Eikon Therapeutics, Inc. (EIKN)	United States	$0.446B
Kyverna Therapeutics, Inc. (KYTX)	United States	$0.434B	-3.60
Editas Medicine, Inc. (EDIT)	United States	$0.424B	-4.29
4D Molecular Therapeutics, Inc. (FDMT)	United States	$0.733B	-4.10